KEAP1 and head and neck squamous cell carcinoma: In conclusion, although Keap1–Nrf2 alterations are known to play roles in chemotherapeutic resistance particularly cisplatin resistance in HNSCC, surprisingly, the mutation status is not widely used to make a treatment decision in head and cancer.